Alprostadil and dyspnoea Patient Reports February 12, 2012
Alprostadil Side Effects Report #4585348-2
Alprostadil side effect was reported by a Consumer or non-health professional from on Feb 07, 2005. Male patient was diagnosed with sudden hearing loss and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: dyspnoea. Alprostadil dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.
Alprostadil Side Effects Report #5786320-7
Alprostadil side effect was reported by a Consumer or non-health professional from POLAND on June 28, 2006. Female patient, 77 years of age, was diagnosed with peripheral ischaemia and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: bronchopneumonia, chest pain
, condition aggravated, disease progression, disease recurrence, dyspnoea, electrolyte imbalance, gastric ulcer haemorrhage, haematemesis. Alprostadil dosage: unknown. During the same period patient was treated with KETOPROFEN, PETHIDINE HYDROCHLORIDE, PETHIDINE HYDROCHLORIDE, FUROSEMIDE, AMLODIPINE, TICLOPIDINE, POTASSIUM CHLORIDE, RANITIDINE HYDROCHLORIDE. Patient was hospitalized. Patient died.Alprostadil Side Effects Report #5519544-4
Alprostadil side effect was reported by a Consumer or non-health professional from POLAND on Oct 26, 2007. Female patient, 71 years of age, was diagnosed with peripheral ischaemia and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: anxiety
, chest pain
, dyspnoea, feeling abnormal, palpitations. Alprostadil dosage: 60 MCG (60 MG 1 IN 1 DAY(S)) INTRAVENOUS DRIP. During the same period patient was treated with GENTAMICIN, DOLARGAN, POLFILIN, SADAMIN, ENOXAPARIN, MIXTARD. Patient was hospitalized. Patient recovered.Alprostadil Side Effects Report #5091658-5
Alprostadil side effect was reported by a Consumer or non-health professional from GERMANY on June 23, 2006. Male patient, 54 years of age, was diagnosed with peripheral ischaemia and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: abscess
, cardiac failure, dyspnoea, foot amputation, impaired healing, left ventricular failure, pulmonary congestion, pulmonary oedema. Alprostadil dosage: unknown. During the same period patient was treated with DICLOFENAC, TRAMADOL, VERAPAMIL, FUROSEMIDE, VALSARTAN, PANTOPRAZOLE, CEFAZOLIN, AMPICILLIN. Patient recovered.Alprostadil Side Effects Report #4750572-2
Alprostadil side effect was reported by a Consumer or non-health professional from JAPAN on Aug 12, 2005. Male patient, 61 years of age, was diagnosed with atherosclerosis obliterans and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: dyspnoea, hypoxia, oedema peripheral, pleural effusion, swelling face. Alprostadil dosage: unknown. During the same period patient was treated with CEFOZOPRAN, CEFEPIME. Patient was hospitalized. Patient recovered.
Alprostadil Side Effects Report #5133061-5
Alprostadil side effect was reported by a Consumer or non-health professional from JAPAN on May 19, 2006. Male patient, 70 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: cardiac failure acute, condition aggravated, dyspnoea, malaise, pain in extremity, palpitations. Alprostadil dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, FUROSEMIDE, WARFARIN POTASSIUM, OMEPRAZOLE, HANP, DOPAMINE HYDROCHLORIDE, DOBUTAMINE. Patient was hospitalized. Patient recovered.
Alprostadil Side Effects Report #4837003-9
Alprostadil side effect was reported by a Consumer or non-health professional from JAPAN on Aug 12, 2005. Male patient, 61 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, cardiomegaly, condition aggravated, dyspnoea, face oedema, hypoxia, mitral valve incompetence. Alprostadil dosage: unknown. During the same period patient was treated with CEFOZOPRAN, CEFEPIME, IMIPENEM, GLIMEPRIDINE, PRAVASTATIN, METFORMIN, IMIDAPRIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Alprostadil Side Effects Report #5839411-6
Alprostadil side effect was reported by a Consumer or non-health professional from GERMANY on July 15, 2008. Female patient, 86 years of age, was diagnosed with arterial occlusive disease and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, oedema. Alprostadil dosage: unknown. Patient recovered.
Alprostadil Side Effects Report #5859321-8
Alprostadil side effect was reported by a Consumer or non-health professional from GERMANY on July 15, 2008. Female patient, 86 years of age, was diagnosed with arterial occlusive disease and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, oedema. Alprostadil dosage: unknown. Patient was hospitalized. Patient recovered.
Alprostadil and dyspnoea 